KR100419842B1 - 한국에서 분리한 신규한 에이형 간염바이러스 뉴클레오티드 서열 - Google Patents
한국에서 분리한 신규한 에이형 간염바이러스 뉴클레오티드 서열 Download PDFInfo
- Publication number
- KR100419842B1 KR100419842B1 KR10-2001-0018829A KR20010018829A KR100419842B1 KR 100419842 B1 KR100419842 B1 KR 100419842B1 KR 20010018829 A KR20010018829 A KR 20010018829A KR 100419842 B1 KR100419842 B1 KR 100419842B1
- Authority
- KR
- South Korea
- Prior art keywords
- hav
- hepatitis
- virus
- yha34
- amino acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
- C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Seg IDNO | Primer list for amplification of HAV |
345678910 11 1213141516 | Upper primerHAV F1:5'- TTC AAG AGG GGT CTC CG- 3'HAV F1(2):5'- TTC AAG AGG GGT CTC CGG AG- 3'HAV F1(3):5'- TTC AAG AGG GGT CTC- 3'HAV F45:5'- CCA TGG TGA GGG GAC TTG ATA CHAV F659:5'- TCT TTG GGG CCT TAT GTG GTG TTT- 3'HAV F690:5'- AGG TAC TCA GGG GCA TTT AGG TT- 3'HAV F1005:5'- GGC TCA CTA CAC ATG CTC TTT TTC- 3'HAV F1439:5'- TTG CAT GGG TTA ACT CCT CTT TCT- 3' 1 HAV F2020 :5- ACA GGT ATA CAA AGT CAG-3 2 HAV F2167 :5- GTT TTG CTC CTC TTT ATC ATG CTA TG-3HAV F2713:5'- TTG GGT KGA AAA GGA GTC AGC- 3'HAV F2870:5'- GAC AGA TTC TAC ATT TGG ATT GGT- 3'HAV F2897:5'- CTA TTC AGA TTG CAA ATT ACA AT- 3'HAV F2982:5'- TTC CTA GAG CTC CAT TAA A- 3' |
1718192021222324252627282930313233343536373839 | 3 HAV F2984 :5- TCC CAG AGC TCC ATT GAA-3HAV F3343:5'- TAT GGC YGC TGG TAG AAG TG- 3'HAV F3671:5'- CAG GGT GTT GGG TTG ATA GCA - 3'HAV F3892:5'- TAT TGG CTG CTC AGT TAT CTC AT - 3'HAV F4277:5'- ATG GCT CAA GTC GAC CCT AAC C- 3'HAV F4429:5'- AGG RGG AGG GAA RAG YTT GAC- 3' HAV F4582:5'- TGG CCA AAA YAC AAC AGA TGA AGA- 3'HAV F5190:5'- CCC GCA AAG AGG AAG AAC C - 3'HAV F5384:5'- TTG GGA GTG AAG GAT GAT TG - 3'HAV F6091:5'- TCC AAT GGC TGT GAT GTT AT- 3'HAV F6543:5'- GGG GTC CAG CTA TTA GTT ATT TTC - 3'HAV F6714:5-TGA TCA GGG AGG CGG GTA GA-3HAV F7170:5'- TTA GRC CTG CAA TTT C- 3'Lower primer HAV R145:5'- TTA CAA ACA AAA CAA AAG GA- 3'HAV R350:5'- ACT GCA AGG CGA CGT CCC AAA CAT- 3'HAV R374:5'- GGT TCA TGA AAG CCA AGT TA- 3'HAV R467:5'- TAT CCG CCG CTG TTA CCC TAT CC- 3'HAV R504:5'- TCG GCG TTG AAT GGT TTT TGT CTT- 3'HAV R785:5'- GGT CAA GGC CAC TCC CAA CAG- 3'HAV R1158:5'- AAG GGT GTG GGG TTT ATC TGA - 3'HAV R1657:5'- CTG GGC AGC TAA AGT TGG A - 3'HAV R1806:5'- CCC CTC CAA AAR CAA AAC ATC TG- 3' HAV R1941:5'- GCA CAA GGG GCA GTA GTT- 3' |
404142 434445464748495051525354 | 4 HAV R2211 :5-CTC CAG AAT GAT C-3 5 HAV R2389 :5-GGA AAT GTC TCA GGT ACT TTC TTT G 3HAV R2868:5'- TTA TCY CCC ARA CCA TCC AGT GCT- 3' 6 HAV R3265 :5-CAT TAT TTC ATG CTC CTC AG-3 HAV R3288:5'- AAC TTC ATT ATT TCA TGC TCC T- 3'HAV R3381:5'- CCA TTT CAA GAG TCC ACA CAC T- 3'HAV R4443:5'- CTC TTC CCT CCC CCT CTT TT - 3'HAV R4443:5'- CTC TTC CCT CCC CCT CTT TT - 3'HAV R5505:5'- TTK CCW GCT GAA ATT GAR TAG TA- 3'HAV R5819:5'- CCA GRG CCC CAC CAC AC- 3'HAV R5820:5'- ACC AGA GCC CCA CCA CA - 3'HAV R6250:5'- RCC TGG AGC CCC TGT AAT GG- 3'HAV R6736:5'- GAT TCY ACC CGC CTC CCT RAT- 3'HAV R7117:5'- TGG CTT CAG TTG AGG CAC ATT- 3'HAV R7479:5'- ATT TAC TGA TAA AAG AAA TAA AC- 3' |
* primer 이름의 번호는 5 끝에 해당하는 HAV genome 위치.**1-6 ; 아래 논문들에서 인용한 primer1, 3, 4, 6 ; PNASUSA, 87, 2867-2871, 19902, 5 ; Journal of Infectious Disease, 163, 286-292, 19916 ; Journal of General virology, 73, 1365-1377, 1992*** ; 나머지 primer들은 기존에 보고된 HAV 유전자 염기 서열을 바탕으로 본 발명에서 자체 설계 |
HAV strain | YHA34 | FH1 | FH2 | FH3 | AH1 | AH2 | AH3 | LA85 USA | MBB(M20273) | HM175 (M14707) | HM175 (NC001489) | HM175 attenuated |
YHA34 Korea | _ | 1.0 | 3.5 | 3.4 | 3.5 | 3.7 | 3.7 | 4.0 | 8.3 | 8.3 | 8.3 | 8.4 |
FH1 Japan | 0.6 | _ | 3.4 | 3.3 | 3.5 | 3.6 | 3.7 | 4.1 | 8.3 | 8.2 | 8.2 | 8.3 |
FH2 Japan | 0.8 | 0.9 | _ | 3.1 | 1.9 | 3.4 | 3.5 | 4.5 | 8.6 | 8.6 | 8.6 | 8.8 |
FH3 Japan | 0.7 | 0.8 | 0.6 | _ | 2.9 | 2.9 | 3.0 | 3.9 | 8.1 | 8.2 | 8.2 | 8.3 |
AH1 Japan | 0.9 | 1.0 | 0.5 | 0.6 | _ | 3.2 | 3.3 | 4.2 | 8.6 | 8.7 | 8.7 | 8.8 |
AH2 Japan | 0.6 | 0.7 | 0.5 | 0.4 | 0.5 | _ | 1.7 | 4.3 | 8.5 | 8.6 | 8.6 | 8.8 |
AH3 Japan | 0.9 | 1.1 | 0.9 | 0.7 | 0.9 | 0.5 | _ | 4.3 | 8.6 | 8.8 | 8.8 | 9.0 |
LA85 USA | 1.1 | 1.2 | 1.1 | 0.9 | 1.2 | 0.9 | 1.3 | _ | 8.4 | 8.3 | 8.3 | 8.5 |
MBB(M20273) | 1.8 | 1.9 | 1.8 | 1.6 | 1.9 | 1.7 | 1.9 | 1.9 | _ | 4.9 | 4.9 | 5.0 |
HM175(M14707) | 1.2 | 1.3 | 1.3 | 1.0 | 1.3 | 1.1 | 1.4 | 1.4 | 0.8 | _ | 0.0 | 0.5 |
HM175(NC001489) | 1.2 | 1.3 | 1.3 | 1.0 | 1.3 | 1.1 | 1.4 | 1.4 | 0.8 | 0.0 | _ | 0.5 |
HM175 attenuated | 1.6 | 1.7 | 1.7 | 1.4 | 1.8 | 1.5 | 1.8 | 1.8 | 1.0 | 0.5 | 0.5 | _ |
Claims (3)
- 서열번호 1의 한국형 A형 간염 백신 제조용으로 이용되는 간염바이러스(HAV-YHA34) 뉴클레오티드 서열.
- 제 1항의 뉴클레오티드 서열로부터 번역되는 서열번호 2의 아미노산 서열.
- 제 2항의 아미노산 서열을 포함하는 한국형 A형 간염바이러스(HAV-YHA34) 항원.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2001-0018829A KR100419842B1 (ko) | 2001-04-10 | 2001-04-10 | 한국에서 분리한 신규한 에이형 간염바이러스 뉴클레오티드 서열 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2001-0018829A KR100419842B1 (ko) | 2001-04-10 | 2001-04-10 | 한국에서 분리한 신규한 에이형 간염바이러스 뉴클레오티드 서열 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20020078708A KR20020078708A (ko) | 2002-10-19 |
KR100419842B1 true KR100419842B1 (ko) | 2004-02-25 |
Family
ID=27700403
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2001-0018829A KR100419842B1 (ko) | 2001-04-10 | 2001-04-10 | 한국에서 분리한 신규한 에이형 간염바이러스 뉴클레오티드 서열 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100419842B1 (ko) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2392445T3 (es) | 2004-07-13 | 2012-12-10 | Gen-Probe Incorporated | Composiciones y métodos para la detección de ácido nucleico del virus de la hepatitis A |
KR100748842B1 (ko) * | 2004-09-09 | 2007-08-13 | 주식회사한국야쿠르트 | 에이형 간염바이러스에 대한 항체 제조방법 및 그 응용 |
KR100861923B1 (ko) * | 2006-12-07 | 2008-10-09 | 메디칸(주) | 바이러스 항원 발현 재조합 벡터로 형질전환된 곤충세포를 이용한 a형 간염 바이러스 항원의 제조방법 |
EP2743355B1 (en) * | 2012-12-13 | 2016-08-10 | F. Hoffmann-La Roche AG | HAV detection |
-
2001
- 2001-04-10 KR KR10-2001-0018829A patent/KR100419842B1/ko active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR20020078708A (ko) | 2002-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2198514T3 (es) | Cebadores y sondas para la deteccion de la hepatitis c. | |
US6194142B1 (en) | Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2, and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses | |
ES2574252T3 (es) | Procedimiento para tipar y detectar el VHB | |
Callens et al. | Differentiation of the seven serotypes of foot-and-mouth disease virus by reverse transcriptase polymerase chain reaction | |
EP0651807B1 (en) | New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents | |
ES2306648T3 (es) | Cebadores de oligonucleotidos para la transcripcion inversa para la deteccion eficaz de vih-1 y vih-2 y procedimientos de uso de los mismos. | |
EP0905258A2 (en) | Method for detecting nucleic acid sequences based on the use of solid phase immobilised nucleotide probes (line probe assay) | |
US8173795B2 (en) | Methods and compositions for identifying and characterizing hepatitis C | |
RO109952B1 (ro) | Procedeu si reactiv pentru detectarea secventei de hcv, intr-o secventa suspectata a contine polinucleotida hcv, care cuprinde o regiune tinta, selectata | |
CA2197569A1 (en) | Nucleotide and amino acid sequences of the envelope 1 and core genes of hepatitis c virus | |
Frangeul et al. | Mutations in NS5A region of hepatitis C virus genome correlate with presence of NS5A antibodies and response to interferon therapy for most common European hepatitis C virus genotypes | |
Qian et al. | Hepatitis C virus mixed genotype infection in patients on haemodialysis | |
Agostini et al. | Molecular evolution and epidemiology of JC virus | |
Kim et al. | Phylogenetic analysis of the small hydrophobic (SH) gene of mumps virus in Korea: identification of a new genotype | |
KR100419842B1 (ko) | 한국에서 분리한 신규한 에이형 간염바이러스 뉴클레오티드 서열 | |
EP0510952A1 (en) | Oligonucleotide primers and their application for high-fidelity detection of non-a, non-b hepatitis virus | |
US7022814B1 (en) | Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2 and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses | |
ES2231822T3 (es) | Deteccion del virus de la hepatitis gb mediante acidos nucleicos. | |
JP2554612B2 (ja) | 相補肝炎aウイルスゲノムを含有している雑種dnaの調製法、該雑種dna、これを含有するプラスミドベクタ−、雑種dnaによって発現されたウイルス特異蛋白質およびこれから調製され、これらを含有するワクチン | |
FR2778415A1 (fr) | Fragment d'adn gc3 specifique de neisseria gonorrhoeae | |
AKASU | Outbreak of Aseptic Meningitis due to ECHO-9 in Northern Kyushu Island inthe Summer of 1997 | |
Kakizawa et al. | Genetic analysis of the capsid region of human astrovirus serotype 3 isolated in Japan | |
Yang et al. | Molecular subtyping of human T‐lymphotropic virus type I (HTLV‐I) by a nested polymerase chain reaction‐restriction fragment length polymorphism analysis of the envelope gene: Two distinct lineages of HTLV‐I in Taiwan | |
Jung et al. | Molecular biological characterization of enterovirus variant isolated from patients with aseptic meningitis | |
Li et al. | Hepatitis B virus genomes of chronic hepatitis patients do not contain specific mutations related to acute exacerbation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
J201 | Request for trial against refusal decision | ||
AMND | Amendment | ||
B701 | Decision to grant | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130304 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20140106 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20150107 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20160205 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20170223 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20180209 Year of fee payment: 15 |
|
FPAY | Annual fee payment |
Payment date: 20190109 Year of fee payment: 16 |
|
FPAY | Annual fee payment |
Payment date: 20200114 Year of fee payment: 17 |